estrone has been researched along with Cardiovascular Diseases in 17 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Testosterone in Older Men with Mobility Limitations Trial found an increased incidence of cardiovascular events in men randomized to testosterone, resulting in enrollment cessation by trial's Data and Safety Monitoring Board." | 2.78 | Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation. ( Basaria, S; Bhasin, S; Davda, MN; Singh, R; Travison, TG; Ulloor, J, 2013) |
| "Estrone was positively associated with smoking, BMI, and testosterone, and total and free estradiol with diabetes, BMI, testosterone, and comorbid conditions; additionally, free estradiol was associated negatively with smoking." | 1.39 | Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. ( Basaria, S; Bhasin, S; Coviello, A; D'Agostino, R; Davda, M; Jasuja, GK; Kushnir, MM; Meikle, W; Murabito, JM; Pencina, MJ; Rockwood, AL; Rose, AJ; Travison, TG; Vasan, RS; Zhang, A, 2013) |
| " In the cigarette smokers, a dose-response relationship was apparent for these hormones with mean levels increasing with increasing reported cigarette consumption." | 1.27 | Cigarette smoking and increased endogenous estrogen levels in men. ( Barrett-Connor, E; Khaw, KT, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gruber, DM | 1 |
| Huber, JC | 1 |
| Thurston, RC | 1 |
| Bhasin, S | 3 |
| Chang, Y | 2 |
| Barinas-Mitchell, E | 1 |
| Matthews, KA | 2 |
| Jasuja, R | 1 |
| Santoro, N | 2 |
| Tomaszewski, M | 1 |
| Charchar, FJ | 1 |
| Maric, C | 1 |
| Kuzniewicz, R | 1 |
| Gola, M | 1 |
| Grzeszczak, W | 1 |
| Samani, NJ | 1 |
| Zukowska-Szczechowska, E | 1 |
| Laughlin, GA | 1 |
| Ix, JH | 1 |
| Cummins, K | 1 |
| Allison, MA | 1 |
| Daniels, LB | 1 |
| Basaria, S | 2 |
| Davda, MN | 1 |
| Travison, TG | 2 |
| Ulloor, J | 1 |
| Singh, R | 1 |
| Jasuja, GK | 1 |
| Davda, M | 1 |
| Murabito, JM | 1 |
| Zhang, A | 1 |
| Kushnir, MM | 1 |
| Rockwood, AL | 1 |
| Meikle, W | 1 |
| Pencina, MJ | 1 |
| Coviello, A | 1 |
| Rose, AJ | 1 |
| D'Agostino, R | 1 |
| Vasan, RS | 1 |
| MYERS, SM | 1 |
| HOPKINS, CE | 1 |
| MARMORSTON, J | 1 |
| Lasley, B | 1 |
| Crawford, S | 1 |
| Pasternak, RC | 1 |
| Sutton-Tyrrell, K | 1 |
| Sowers, M | 1 |
| Curcio, JJ | 1 |
| Wollner, DA | 1 |
| Schmidt, JW | 1 |
| Kim, LS | 1 |
| Smetnik, VP | 1 |
| Wilcox, JG | 1 |
| Hatch, IE | 1 |
| Gentzschein, E | 1 |
| Stanczyk, FZ | 1 |
| Lobo, RA | 1 |
| Koh, KK | 1 |
| Blum, A | 1 |
| Hathaway, L | 1 |
| Mincemoyer, R | 1 |
| Csako, G | 1 |
| Waclawiw, MA | 1 |
| Panza, JA | 1 |
| Cannon, RO | 1 |
| Vehkavaara, S | 1 |
| Silveira, A | 1 |
| Hakala-Ala-Pietilä, T | 1 |
| Virkamäki, A | 1 |
| Hovatta, O | 1 |
| Hamsten, A | 1 |
| Taskinen, MR | 1 |
| Yki-Järvinen, H | 1 |
| Khaw, KT | 2 |
| Barrett-Connor, E | 2 |
| Rudy, DR | 1 |
| Wilson, JL | 1 |
| Ashburn, AD | 1 |
| Williams, WL | 1 |
1 review available for estrone and Cardiovascular Diseases
| Article | Year |
|---|---|
Conjugated estrogens--the natural SERMs.
Topics: 2-Methoxyestradiol; Anticarcinogenic Agents; Cardiovascular Diseases; Dihydrotestosterone; Equilin; | 1999 |
4 trials available for estrone and Cardiovascular Diseases
| Article | Year |
|---|---|
Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Estradiol; Estrone; Fibrinogen; Human | 2013 |
Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Cardiovascular Diseases; Cholesterol; Endoth | 1997 |
Vascular effects of estrogen and vitamin E therapies in postmenopausal women.
Topics: Analysis of Variance; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Estradiol; E | 1999 |
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Apolipoproteins; Biomarkers; Blood Coagulation; Blo | 2001 |
12 other studies available for estrone and Cardiovascular Diseases
| Article | Year |
|---|---|
Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women.
Topics: Adult; Asymptomatic Diseases; Brachial Artery; Cardiovascular Diseases; Carotid Intima-Media Thickne | 2018 |
Association between lipid profile and circulating concentrations of estrogens in young men.
Topics: Adolescent; Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cardiovascular System; | 2009 |
Extremes of an aromatase index predict increased 25-year risk of cardiovascular mortality in older women.
Topics: Aged; Aged, 80 and over; Androstenedione; Aromatase; California; Cardiovascular Diseases; Estrone; F | 2012 |
Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alcohol Drinking; Biomarkers; Body Mass Index; Boston; Cardio | 2013 |
THE EFFECT OF TREATMENT WITH CONJUGATED EQUINE ESTROGEN PREPARATIONS ON ESTROGEN EXCRETION IN MALE SUBJECTS WITH MYOCARDIAL INFARCTION.
Topics: Body Fluids; Cardiovascular Diseases; Creatine; Creatinine; Estradiol; Estriol; Estrogens; Estrogens | 1964 |
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.
Topics: Adult; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Cardiovascular Diseases; Co | 2006 |
Is bio-identical hormone replacement therapy safer than traditional hormone replacement therapy?: a critical appraisal of cardiovascular risks in menopausal women.
Topics: Cardiovascular Diseases; Estriol; Estrogen Replacement Therapy; Estrone; Female; Hormone Replacement | 2006 |
[Principles of replacement hormone therapy in climacteric disorders].
Topics: Adult; Aged; Cardiovascular Diseases; Climacteric; Estradiol; Estriol; Estrogen Replacement Therapy; | 1995 |
Lower endogenous androgens predict central adiposity in men.
Topics: Adult; Aged; Androgens; Androstenedione; Body Constitution; Body Mass Index; Cardiovascular Diseases | 1992 |
Hormone replacement therapy. How to select the best preparation and regimen.
Topics: Cardiovascular Diseases; Climacteric; Contraindications; Estradiol; Estrogen Replacement Therapy; Es | 1990 |
Cigarette smoking and increased endogenous estrogen levels in men.
Topics: Adult; Aged; Androstenedione; Cardiovascular Diseases; Estradiol; Estrone; Humans; Male; Middle Aged | 1987 |
Effects of sex hormones on diet-induced atrial thrombosis.
Topics: Animals; Body Weight; Cardiovascular Diseases; Cardiovascular System; Caseins; Castration; Coronary | 1970 |